AptLNP Delivery System
Targeted delivery of genetic medicines to extrahepatic tissues
Platform/Pre-clinicalActive Development
Key Facts
Indication
Targeted delivery of genetic medicines to extrahepatic tissues
Phase
Platform/Pre-clinical
Status
Active Development
Company
About Atom Bioworks
Atom Bioworks is pioneering the use of AI to overcome the limitations of traditional aptamer discovery, aiming to create a new generation of genetic medicines. The company has developed the proprietary AptaBLE AI platform, which accelerates aptamer design from months to days and outperforms structure-based tools like AlphaFold3 in binding prediction. Strategic recognitions include selection into the Google Cloud for AI Startup program and the NVIDIA Inception program, positioning the company at the intersection of computational biology and drug development.
View full company profile